Genomic Medicine Sweden
Genomic Medicine Sweden, GMS, is paving the way for improved diagnostics, care and treatment.
News
National initiative to deliver more precise drug treatment
The answer to why medicines work differently in different people is often found in our genes. Genomic Medicine Sweden is now taking a major step towards making pharmacogenetic testing available at all university hospitals. With a national gene panel, more patients...
Government Proposes New National Coordination Structure for Precision Health
The government has decided on a national coordination structure for precision health, with the goal that all patients will have equal access to the personalised care of the future. The assignment has been given to the National Board of Health and Welfare, which,...
Genomic Medicine Sweden launches new report on advances in precision medicine
Genomic Medicine Sweden (GMS) has published the report Collaboration in Precision Medicine since 2017, which summarises recent developments in precision medicine in Sweden. The report shows how national collaboration between healthcare, academia, government agencies,...
Sweden’s ambitious national collaboration for genomic medicine
Our strategic mission is to foster collaboration between healthcare providers, academia, patient organizations and industry and realize precision medicine by effectively utilizing the rapidly advancing sequencing technologies to provide the highest standards of genomic testing in routine clinical care throughout Sweden.
Healthcare
A close collaboration between healthcare and academia is central in introducing new forms of diagnostics as the basis for an individualized choice of treatment.
Patients & next of kin
Participation and knowledge from patients and next of kin representatives is crucial for GMS to be able to introduce precision medicine in health care based on the individual’s needs.
Industry
Through an active collaboration with industry, GMS will develop and provide tomorrow´s solutions for the diagnostics and treatment of various diseases.
Academia
GMS forms a strong basis for researchers to better understand why disease arises and how new forms of treatment can be developed.
Regional centers
Seven regional centers are the GMS engine
GMS is comprised of seven regional Genomic Medicine Centers (GMC). These joint centers act as the primary point of contact for sequencing patient samples within healthcare, thereby creating an integrated platform for both healthcare delivery and advanced medical research. Each GMC is a collaboration between a region with university hospital care, a university with a faculty of medicine, and SciLifeLab.
Participating partners
In collaboration with
